| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A chemical genetics approach to identify therapeutic vulnerabilities in Gefitinib resistant, EGFR T790M
|
Low, J.
|
|
|
28 |
S7 |
p. vii18
|
artikel
|
| 2 |
Actionable molecular alterations in advanced gynecologic malignancies: updated results from the ProfiLER program in France
|
Le Saux, O.
|
|
|
28 |
S7 |
p. vii14
|
artikel
|
| 3 |
A genome-wide CRISPR cell growth screen identifies NCAPG as a new therapeutic target for hepatocellular carcinoma
|
Wang, Y.
|
|
|
28 |
S7 |
p. vii14
|
artikel
|
| 4 |
All-in-one RNA-based assay to detect therapeutic biomarkers in lung cancer
|
Wei, J.
|
|
|
28 |
S7 |
p. vii10
|
artikel
|
| 5 |
A model based adjustment for tumor mutational burden across different tumor types
|
Wang, M.H.
|
|
|
28 |
S7 |
p. vii13
|
artikel
|
| 6 |
Analysis of phosphorylation pattern of RTK and MAPK signaling pathways in pediatric neurogenic tumors
|
Macigova, P.
|
|
|
28 |
S7 |
p. vii19
|
artikel
|
| 7 |
A new therapeutic approach to auto-immune diseases: Endotherapia
|
Vidal, L.
|
|
|
28 |
S7 |
p. vii13
|
artikel
|
| 8 |
A Qualitative Study on Views and Perspectives of Non-Governmental Organisations on Implementation of Personalised Medicine in Cancer Patients
|
Gill, J.
|
|
|
28 |
S7 |
p. vii5
|
artikel
|
| 9 |
ARCHITECT® urine-Neutrophil Gelatinase-Associated Lipocalin (uNGAL) essay: New prognostic marker for clear cell Renal Cell Carcinoma (ccRCC)
|
Saint, F.
|
|
|
28 |
S7 |
p. vii9
|
artikel
|
| 10 |
A single-nucleotide polymorphism of ABCB1 (MDR1) is correlated with poor response to Imatinib chronic myeloid leukemia
|
Glady, L.
|
|
|
28 |
S7 |
p. vii5-vii6
|
artikel
|
| 11 |
Author index
|
|
|
|
28 |
S7 |
p. vii33-vii36
|
artikel
|
| 12 |
Census of cancer genes from a comprehensive review of cancer gene panels
|
Kanta, E.
|
|
|
28 |
S7 |
p. vii6-vii7
|
artikel
|
| 13 |
CHEK2 gene mutations in breast cancer patients with BRCA1/2 positive or negative status
|
Lobanova, O.
|
|
|
28 |
S7 |
p. vii7
|
artikel
|
| 14 |
Circulating cell free DNA as a biomarker in the serum of colorectal cancer patients
|
Alhanafy, A.
|
|
|
28 |
S7 |
p. vii31
|
artikel
|
| 15 |
Circulating tumour DNA and oncometabolites in patients with intrahepatic cholangiocarcinoma
|
Winter, H.
|
|
|
28 |
S7 |
p. vii10-vii11
|
artikel
|
| 16 |
Comprehensive molecular and phenotypic profiling of end-stage IV cancer identifies treatable targets and improves survival in individual patients
|
Samsen, A.
|
|
|
28 |
S7 |
p. vii22
|
artikel
|
| 17 |
Decision support system for the interpretation of multiplex genetic tests in gastrointestinal cancers
|
Fábián, O.
|
|
|
28 |
S7 |
p. vii4
|
artikel
|
| 18 |
Design of targeted next-generation sequencing (NGS) of circulating tumour DNA (ctDNA): towards overcoming DNA
|
Mileyko, V.
|
|
|
28 |
S7 |
p. vii8
|
artikel
|
| 19 |
Detection of cancer associated mutations in exhaled breath condensates of healthy subjects by next generation sequencing
|
Youssef, O.
|
|
|
28 |
S7 |
p. vii11
|
artikel
|
| 20 |
Diagnostic value of anti-glycan antibodies in patients with colorectal cancer
|
Tikhonov, A.
|
|
|
28 |
S7 |
p. vii10
|
artikel
|
| 21 |
DNA and RNA analysis of intratumour heterogeneity in metastatic clear cell renal cell carcinoma
|
Ferronika, P.
|
|
|
28 |
S7 |
p. vii31
|
artikel
|
| 22 |
Dual targeting of C-kit and Integrin Linked Kinase abrogates the phosphorylation of S6 ribosomal protein and reduces melanoma cell growth
|
Mabeta, P.
|
|
|
28 |
S7 |
p. vii18
|
artikel
|
| 23 |
Early detection of circulating tumor DNA for the assessment of resistance or relapse to neoadjuvant chemotherapy in breast cancer patients
|
Isnaldi, E.
|
|
|
28 |
S7 |
p. vii5
|
artikel
|
| 24 |
Editorial board
|
|
|
|
28 |
S7 |
p. ii-iii
|
artikel
|
| 25 |
Expression of stem cell and mesenchymal markers in circulating tumor cells is associated with poor prognosis of early breast cancer patients
|
Nagel, A.
|
|
|
28 |
S7 |
p. vii32
|
artikel
|
| 26 |
Expression of TGF-b and CD-44 in age specific subgroup of patients with adenocarcinoma of gastric cardia
|
Lukavetskyy, N.
|
|
|
28 |
S7 |
p. vii30
|
artikel
|
| 27 |
Extensive global alternative splicing induced by hypoxia across four major cancer types
|
Cheng, W.C.
|
|
|
28 |
S7 |
p. vii25
|
artikel
|
| 28 |
Feasibility of precision oncology virtual tumour boards to optimise direct point-of-care management and clinical trial enrolment of advanced cancer patients: New models for personalised oncology
|
Loaiza-Bonilla, A.
|
|
|
28 |
S7 |
p. vii7
|
artikel
|
| 29 |
Gene expression changes responsible for lapatinib acquired resistance in HER2 positive gastric cancer cell lines: a microarray analysis
|
Gambardella, V.
|
|
|
28 |
S7 |
p. vii16
|
artikel
|
| 30 |
Genetic panel sequencing for advanced stage cancer disease in the clinic
|
Hilke, F.
|
|
|
28 |
S7 |
p. vii17
|
artikel
|
| 31 |
Genome-wide identification of actionable copy number alterations from targeted sequencing panels with Excavator2
|
Mazzarella, L.
|
|
|
28 |
S7 |
p. vii2-vii3
|
artikel
|
| 32 |
Glut3 addiction is a druggable vulnerability for a molecularly defined subpopulation of glioblastoma
|
Cosset, É
|
|
|
28 |
S7 |
p. vii24
|
artikel
|
| 33 |
HDACs Play a Role in Development of GDC-0980 Resistance in H1975 Lung Adenocarcinoma
|
Hmmier, A.
|
|
|
28 |
S7 |
p. vii28-vii29
|
artikel
|
| 34 |
Identification of molecular mechanisms that confer therapy response to CDK4/6 inhibition using a genome-wide CRIPR-dCsa9 gain-of-function screen
|
Pan, Q.
|
|
|
28 |
S7 |
p. vii15
|
artikel
|
| 35 |
Immune-stroma-histological (ISH)-risk score identifies low-risk group within LN-positive breast cancers
|
Grigoriadis, A.
|
|
|
28 |
S7 |
p. vii27-vii28
|
artikel
|
| 36 |
Immunoregulatory Protein B7-H3 Promotes Growth and Decreases Tumor Cell Sensitivity to Anti-Cancer Agents
|
Nunes-Xavier, C.
|
|
|
28 |
S7 |
p. vii12
|
artikel
|
| 37 |
Implications of routine NGS testing for daily clinical practice – the Zurich experience with the OFA panel
|
Britschgi, C.
|
|
|
28 |
S7 |
p. vii15
|
artikel
|
| 38 |
In search of germline variants associated with metastasis risk in sporadic colorectal carcinomas: towards personalized therapeutic decision
|
Thean, L.F.
|
|
|
28 |
S7 |
p. vii22-vii23
|
artikel
|
| 39 |
In-situ detection and characterization of EGFR and EGFRvIII expression heterogeneity in glioblastoma FFPE tissues
|
Harms, U.
|
|
|
28 |
S7 |
p. vii17
|
artikel
|
| 40 |
Interrogating functional dependencies between genomic alterations can facilitate precision medicine approaches in cancer
|
Mina, M.
|
|
|
28 |
S7 |
p. vii2
|
artikel
|
| 41 |
Intratumor heterogeneity in chemo-naïve localized invasive ductal carcinomas
|
Vicier, C.
|
|
|
28 |
S7 |
p. vii1
|
artikel
|
| 42 |
Involvement of microRNA-146a in trastuzumab resistance of HER2+ breast cancer cells
|
Cabello, P.
|
|
|
28 |
S7 |
p. vii25-vii26
|
artikel
|
| 43 |
Is Androgen Receptor a predicitive biomarker of response to antiestrogen therapy in advanced breast cancer?
|
Ravaioli, S.
|
|
|
28 |
S7 |
p. vii22
|
artikel
|
| 44 |
Longitudinal circulating-tumor DNA profiling of EGFR-mutated lung adenocarcinoma patients treated with EGFR-tyrosine kinase inhibitors
|
Ortiz-Cuaran, S.
|
|
|
28 |
S7 |
p. vii1
|
artikel
|
| 45 |
Melatonin Inhibits the Metastatic Ability of HER2/neu-negative Breast Cancer Cells by Suppressing Epithelial-to-Mesenchymal Transition (EMT)-Associated Genes with Predictive and Prognostic Relevance
|
Tavartkiladze, A.
|
|
|
28 |
S7 |
p. vii30
|
artikel
|
| 46 |
Micro-RNA 33b inhibits breast cancer migration and invasion through regulating epithelial-mesenchymal transition in HER2 positive breast cancer cell lines
|
Pattanayak, B.
|
|
|
28 |
S7 |
p. vii19-vii20
|
artikel
|
| 47 |
Migration of normal stem CD34 + cells to the brain in experimental models of ischemic stroke and glioblastoma
|
Zayats, Y.
|
|
|
28 |
S7 |
p. vii30
|
artikel
|
| 48 |
Molecular analysis of Epidermal growth factor receptor variant III and glucose transporter expressions in different grades of glioma: potential biomarkers for targeted therapy
|
Xavier, S.
|
|
|
28 |
S7 |
p. vii23
|
artikel
|
| 49 |
Molecular characteristics of Angiopoietin 2-associated Colorectal Carcinoma
|
Jary, M.
|
|
|
28 |
S7 |
p. vii31-vii32
|
artikel
|
| 50 |
Molecular profiling of recurrent and metastatic salivary gland cancer to personalise cancer therapy
|
Rack, S.
|
|
|
28 |
S7 |
p. vii21-vii22
|
artikel
|
| 51 |
Neuroblastoma PTPome analysis unveils association of DUSP5 and PTPN1 expression with poor prognosis
|
Pulido, R.
|
|
|
28 |
S7 |
p. vii21
|
artikel
|
| 52 |
New cell line models for the development of personalized therapy for high grade serous ovarian cancer
|
Castillo-Tong, D.
|
|
|
28 |
S7 |
p. vii15-vii16
|
artikel
|
| 53 |
New potential biomarkers for breast cancer prognosis
|
Havrysh, K.
|
|
|
28 |
S7 |
p. vii6
|
artikel
|
| 54 |
NGS for detection of mutations of the EGFR gene in plasma DNA of patients with the lung cancer
|
Pisareva, E.
|
|
|
28 |
S7 |
p. vii21
|
artikel
|
| 55 |
Novel therapeutic targets identification in breast cancer by systems biology approach
|
Peer Mohammed, M.
|
|
|
28 |
S7 |
p. vii21
|
artikel
|
| 56 |
Number of predicted tumour-neoantigens as biomarker for cancer immunotherapies
|
Armeanu-Ebinger, S.
|
|
|
28 |
S7 |
p. vii12
|
artikel
|
| 57 |
Phase 1-2 study of progesterone receptor (PR) inhibition with extended-release (ER) onapristone (ONA) alone or in combination with abiraterone (AA) in patients (pts) with castration-resistant prostate cancer (CRPC) incorporating plasma DNA analysis to define androgen receptor (AR) status
|
Jayaram, A.
|
|
|
28 |
S7 |
p. vii30
|
artikel
|
| 58 |
P57-mediated autophagy promotes the efficacy of EGFR inhibitors in hepatocellular carcinoma
|
Li, Q.
|
|
|
28 |
S7 |
p. vii18
|
artikel
|
| 59 |
Practical screening system of oncogenic driver fusions in lung adenocarcinoma, using the NanoString nCounter
|
Takamochi, K.
|
|
|
28 |
S7 |
p. vii9-vii10
|
artikel
|
| 60 |
Precision systems medicine in urological Tumors – Molecular profiling and functional testing
|
Saeed, K.
|
|
|
28 |
S7 |
p. vii2
|
artikel
|
| 61 |
Precision Trial Designer: A computational tool to assist in the design of genomics-driven trials in oncology
|
Mazzarella, L.
|
|
|
28 |
S7 |
p. vii3-vii4
|
artikel
|
| 62 |
PREDMED® TEST, new normalized expression method to predict the effect of tumor- and microenvironment-targeted therapies
|
Fritz, J.
|
|
|
28 |
S7 |
p. vii5
|
artikel
|
| 63 |
PROFILER 02 - A multicentric, prospective cohort study aiming to evaluate the added value of a large molecular profiling panel (315 cancer-related gene panel [FoundationOne]) versus a limited molecular profiling panel (74 cancer-related gene panel [CONTROL]) in advanced solid tumours
|
Blay, J-Y
|
|
|
28 |
S7 |
p. vii4
|
artikel
|
| 64 |
Readthrough response of pathogenic premature termination codons at PTEN gene: implications in precision therapy for PHTS patients
|
Luna, S.
|
|
|
28 |
S7 |
p. vii7-vii8
|
artikel
|
| 65 |
Relationship between tumor microenviroment and development and progression of cancer: A Review
|
Mishra, A.
|
|
|
28 |
S7 |
p. vii32
|
artikel
|
| 66 |
Role of DNA repair gene polymorphisms in prediction of radiation toxicity in oropharyngeal cancers
|
Gupta, A.
|
|
|
28 |
S7 |
p. vii6
|
artikel
|
| 67 |
Role of E-cadherin in metastatic colorectal cancer treatment
|
Hanušová, V.
|
|
|
28 |
S7 |
p. vii28
|
artikel
|
| 68 |
Role of Functional Polymorphisms of VEGF and risk of breast cancer in north-western Indians: A Case-Control Study
|
Guleria, K.
|
|
|
28 |
S7 |
p. vii16-vii17
|
artikel
|
| 69 |
Role of Humanized EGFR Monoclonal Antibody as Induction Chemotherapy in Advanced Head and Neck Cancer along with Chemo-Radiation
|
Mishra, A.
|
|
|
28 |
S7 |
p. vii19
|
artikel
|
| 70 |
Role of Intensity Modulated Radiotherapy with Concurrent and Adjuvant Chemotherapy With Temozolamide in Glioblastoma Multiforme
|
Gill, J.
|
|
|
28 |
S7 |
p. vii24
|
artikel
|
| 71 |
SRC-S6 axis as a potential mechanism of resistance to anti HER2 treatment in gastric cancer (GC) cell lines
|
Gambardella, V.
|
|
|
28 |
S7 |
p. vii16
|
artikel
|
| 72 |
Systematic identification of epigenetic alterations across human cancers therapeutic targets in cancer
|
Saghafinia, S.
|
|
|
28 |
S7 |
p. vii14
|
artikel
|
| 73 |
Table of Contents
|
|
|
|
28 |
S7 |
p. iv
|
artikel
|
| 74 |
The application of liquid biopsies in metastatic salivary gland cancer to identify candidate therapeutic targets
|
Metcalf, R.
|
|
|
28 |
S7 |
p. vii8
|
artikel
|
| 75 |
The ERK5 signaling pathway regulates transcription in cancer
|
Pearson, A.
|
|
|
28 |
S7 |
p. vii20
|
artikel
|
| 76 |
The investigation of S100B protein in the development of triple negative breast cancer
|
Huang, Y.C.
|
|
|
28 |
S7 |
p. vii31
|
artikel
|
| 77 |
The landscape of kinase fusions in 445 Chinese NSCLC patients
|
Chen, M.W.
|
|
|
28 |
S7 |
p. vii16
|
artikel
|
| 78 |
The relevance of precision epitope mapping for accurate oncologic diagnostic based on PTEN protein expression in tumours
|
Mingo, J.
|
|
|
28 |
S7 |
p. vii8-vii9
|
artikel
|
| 79 |
The remarkable complete response and improvement of performance status to pembrolizumab of a recurrent microsatellite instability high, metastatic colon cancer, previously treated with Cetuximab, FOLFOX and Irinotecan
|
Oracion, K.
|
|
|
28 |
S7 |
p. vii19
|
artikel
|
| 80 |
The 5T4 oncofetal glycoprotein does not act as a general organizer of the CXCL12 system in cancer cells
|
Koch, C.
|
|
|
28 |
S7 |
p. vii17-vii18
|
artikel
|
| 81 |
Total FAK protein expression is related with anti-angiogenic therapy response in colorectal cancer models
|
Cruz Ramos, M.
|
|
|
28 |
S7 |
p. vii26-vii27
|
artikel
|
| 82 |
Tumor cell-intrinsic expression of immune checkpoint molecules revealed by RNA in situ hybridization
|
Harms, U.
|
|
|
28 |
S7 |
p. vii28
|
artikel
|
| 83 |
Use of NGS for stratification of patients with advanced NSCLC within the NHS using FFPE-extracted DNA from diagnostic biopsies
|
Subramaniam, S.
|
|
|
28 |
S7 |
p. vii9
|
artikel
|
| 84 |
Variations in PD1, PD-L1, IDO1 and VEGR2 genes and association with outcomes in advanced head and neck squamous cell carcinoma (HNSCC) patients treated with anti-PD1/PD-L1 based immunotherapy
|
Saâda-Bouzid, E.
|
|
|
28 |
S7 |
p. vii12
|
artikel
|
Tijdschrift beschrijving